K Number
K061228
Manufacturer
Date Cleared
2006-05-26

(24 days)

Product Code
Regulation Number
872.5570
Panel
Dental
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use
  1. Full Breath Sleep Appliance With Posterior Tongue Depressor- This appliance is indicated for the treatment of snoring.
  2. Full Breath Sleep Appliance With Posterior Tongue Depressor This appliance is indicated for the treatment of mild to moderate obstructive sleep apnea.
Device Description

Not Found

AI/ML Overview

The provided text does not contain information about acceptance criteria or a study that proves the device meets specific acceptance criteria. Instead, it is a 510(k) summary and FDA decision letter for a medical device called the "Full Breath Sleep Appliance With Posterior Tongue Depressor."

Here's what the document does provide:

  • Device Name: Full Breath Sleep Appliance With Posterior Tongue Depressor (and other variations)
  • Applicant: Bryan Keropian DDS
  • Proposed Product Code: LQZ
  • Proposed Device Classification: Jaw Repositioning Device
  • Indications for Use:
    • Treatment of snoring
    • Treatment of mild to moderate obstructive sleep apnea
  • Substantial Equivalence (SE) Claim: The device claims substantial equivalence to several predicate devices for the treatment of mild and moderate OSA, snoring, and bruxism.

The document focuses on establishing substantial equivalence to previously cleared devices rather than presenting new performance data against specific acceptance criteria. This is common for 510(k) submissions, where the primary goal is to show that a new device is as safe and effective as a legally marketed predicate device.

Therefore, I cannot populate the requested table or provide information about a study proving acceptance criteria as that data is not present in the provided text.

{0}------------------------------------------------

K061228

MAY 2 6 2006

510(k) Summary Full Breath Sleep Appliance Anterior Bite With Posterior Tongue Depressor Full Breath Sleep Appliance Posterior Bite With Posterior Tongue Depressor

Applicant

Bryan Keropian DDS 18607 Ventura Blvd., Suite 206 Tarzana, CA 91356

Product Name

Full Breath Sleep Appliance Anterior Bite With Posterior Tongue Depressor Full Breath Sleep Appliance Posterior Bite With Posterior Tongue Depressor

Proposed Product Code LQZ

Proposed Device Classification Jaw Repositioning Device

Contact Person

Bryan Keropian DDS tmjrelief(@msn.com

Telephone

W - 818-881-7233 H-818-716-0579 C - 818-251-0541

Fax

818-881-7541

510(k) Application Preparation Bryan Keropian, DDS

{1}------------------------------------------------

K06/228
20fz

510(K) Summary (continued)

For the treatment of mild and moderate OSA, the Full Breath Sleep Appliance With Posterior Tongue Restrainer is substantially equivalent (SE) to the Quiet Night & Quiet Night MA (K032410), The Full Breath Sleep Appliance Anterior Bite With and Without Bumps (K052862), and the Full Breath Sleep Appliance Posterior Bite With and Without Bumps (K053065)

For the treatment of snoring, the Full Breath Appliance With Posterior Tongue Restrainer is SE to the Quiet Night & Quiet Night MA (K032410), The Full Breath Sleep Appliance Anterior Bite With and Without Bumps (K052862), and the Full Breath Sleep Appliance Posterior Bite With and Without Bumps (K053065), the Breathe EZ Anti-Snoring Device (K022891), the SleepBite (K103808), and Dr. B's Mouthpiece (K991948).

For the treatment of bruxism, the Full Breath Sleep Appliance is SE to the NTI Tension
Supression System (K010876), the Breathe EZ Anti-Snoring device (K022891), the SleepBite
(K103808). And Dr. B's Mouthpiece (K991948).
ProductNameFull BreathSleep Appl.FBAB&FBPBQuiet NightQuiet Nt. MANTI TensionSuppressionSystemBreathe EZAnti-SnoringDeviceSleepbiteDr. B'sMouthpiece
510(k)K052862K053065K032410K010876K022891K103808K991948
ProductCodeLOZLOZLOZLRKLRKLRK
IndicatedUseTreatment ofMild & Mod.OSA--Treatment ofMild & Mod.OSA--Prophylactictreatment ofmedicallydiagnosedmigraine pain--
Treatment ofSnoring--Treatment ofSnoring--Treatment ofsnoring--Treatment ofsnoring--Treatment ofsnoring--
PreventBruxismPreventBruxismPreventBruxismPreventBruxismPreventBruxismPreventBruxism
Method ofDeliveryBy prescriptionBy prescriptionBy prescriptionBy prescriptionBy prescriptionBy prescription

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the words "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" arranged in a circular pattern around the symbol. The caduceus is depicted in black, and the text is also in black. The overall design is simple and recognizable, representing the department's focus on health and human welfare.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAY 2 6 2006

Dr. Bryan Keropian Bryan Keropian, DDS 18607 Ventura Boulevard, Suite 206 Tarzana, California 91356

Re: K061228

Trade/Device Name: Full Breath Sleep Appliance with Posterior Tongue Depressor Regulation Number: 872.5570 Regulation Name: Intraoral Devices for Snoring and Intraoral Devices for Snoring and Obstructive Sleep Apnea Regulatory Class: LQZ Product Code: II Dated: May 2, 2006

Received: May 2, 2006

Dear Dr. Keropian:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Page 2 -Dr. Keropian

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely wours,

Susan Runox

Chiu Lin, Ph.D. Director

Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

K061228

Indications for Use

510(k) Number (if known):

Device Name: Full Breath Sleep Appliance With Posterior Tongue Depressor

Indications For Use:

    1. Full Breath Sleep Appliance With Posterior Tongue Depressor- This appliance is indicated for the treatment of snoring.
    1. Full Breath Sleep Appliance With Posterior Tongue Depressor This appliance is indicated for the treatment of mild to moderate obstructive sleep apnea.

X Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Susan
(vision Sign-C
Envision of Anesthesiology, General Hospital,
Infection Control, Dental Devices

510(%) Number ..

§ 872.5570 Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea.

(a)
Identification. Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea are devices that are worn during sleep to reduce the incidence of snoring and to treat obstructive sleep apnea. The devices are designed to increase the patency of the airway and to decrease air turbulence and airway obstruction. The classification includes palatal lifting devices, tongue retaining devices, and mandibular repositioning devices.(b)
Classification. Class II (special controls). The special control for these devices is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA.”